DIVISLAB's weekly performance was lackluster, with a return of -0.52% and a Sharpe Ratio of -0.23, indicating poor risk-adjusted returns. The stock's volatility was relatively low at 9.01%, but still experienced a max drawdown of -0.92%. Compared to its peers, DIVISLAB outperformed DRREDDY and CIPLA, but underperformed SUNPHARMA. Overall, the stock's risk profile was moderate this week.

[Volatility: 9.01%]